In Vivo Evaluation of Folate Decorated Cross-Linked Micelles for the Delivery of Platinum Anticancer Drugs-Reference-Cited by-同舟云学术

In Vivo Evaluation of Folate Decorated Cross-Linked Micelles for the Delivery of Platinum Anticancer Drugs

Published:2015-01-22 Issue:2 Volume:16 Page:515-523
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Eliezar Jeaniffer¹,Scarano Wei¹,Boase Nathan R. B.²,Thurecht Kristofer J.²,Stenzel Martina H.¹

Affiliation:

1. Centre for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia

2. Centre for Advanced Imaging (CAI) and Australian Institute for Bioengineering and Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia, QLD 4072, Australia

Funder

Australian Research Council

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/bm501558d

Reference42 articles.

1. Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

2. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

3. Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS

4. Pharmacokinetics and Biodistribution of Nanoparticles

5. Long circulating microparticulate drug carriers

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

2. Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy;Coordination Chemistry Reviews;2024-06

3. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer;International Journal of Nanomedicine;2023-10

4. Anticancer analysis of CD44 targeted Cyclosporine loaded thiolated chitosan nanoformulations for sustained release in triple-negative breast cancer.;2023-08-24

5. Anticancer analysis of CD44 targeted Cyclosporine loaded thiolated chitosan nanoformulations for sustained release in triple-negative breast cancer.;2023-08-02